The FDA has agreed to permit limited use of Novartis’ Zelnorm (tegaserod maleate) by some patients through a restricted access program, following the drug’s voluntary withdrawal over cardiovascular ...
Alfasigma USA Inc., which has a commercial hub in Bedminster, announced on Monday it has acquired the brand Zelnorm (tegaserod), a prescription pharmaceutical treatment for irritable bowel syndrome ...
BEDMINSTER, N.J., July 23, 2020 (GLOBE NEWSWIRE) -- Alfasigma USA, Inc. today announced a strategic deal with Indegene, Inc., a global life sciences and healthcare solutions provider, to co-promote ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results